Monograph
M01AC02 - Tenoxicam |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate of CYP 2C9. Two references consider it (probably) safe for use.
Chemical description
Tablet; 20 mg/d. Analgesic with antipyretic och anti-inflammatory effects for short-time treatment of light to moderate pain Oxicam derivative extensively metabolized (CYP 2C9), mainly to the 5-hydroxyderivative. Inhibitor of CYP 2C9. South African list: use with care. French list: authorized
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025